RxDoctor Payments Data

Krisandra Edwards

Family · Mooresville, NCNPI 1346726494

Payments from drug & device makers

$1,465in general payments, 2019–2025

Across 62 payments — averaging $23.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$291
  • Mayne Pharma Commercial LLC$219
  • Astellas Pharma US Inc$173
  • Exeltis, USA Inc.$92
  • Pfizer$85
  • Organon$79
  • plus $526 from 11 others

What the payments were for

  • Food & beverage$1,465100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,465 in reported general payments places this provider in the 75th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$4,567
Medicare patients
34
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluconazole21$79

Paid to pharmacies, not to this prescriber.

Other family in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →